Bonito Biosciences
bonitobio.com
Actively hiring
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1-10
employees, estimated range
Backers
1
Lightstone Ventures
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Lightstone Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
The Cellanome live-cell, multimodal platform links molecular, functional, and temporal data from the same cells over time. Our proprietary…
Visualize live cell function at scale with Pixel™: power cell biology discovery with insights on viability, morphology, ephys, & more.
Antibody medicines that do more. Metaphore's platform brings together live-cell experimentation and AI/ML to understand how biological…
Get the most out of active ingredients and live cells to improve product performance and unlock new forms of treatment using efficient and…
Ramona builds the world's fastest live-cell and small-organism imaging systems. Image a full 96-well plate in under 2 minutes with…
News
Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics
Collaboration combines Bonito's proprietary functional delivery data engine and ligand discovery platform with DaltonTx's adaptive AI technology to accelerate precision oligotherapeutic delivery, beginning in the CNS WALTHAM, Mass. and LONDON, May 27, 202
Read more
Report